Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
GLAXOSMITHKLINE NZ LIMITED,Recombinant Zoster Vaccine,MƒÅori and Pacific people aged 60 years and over for the prevention of herpes zoster and post-herpetic neuralgia,Recombinant Zoster Vaccine (SHINGRIX),,Community and Hospital,
